Published in Nutr Metab Cardiovasc Dis on December 05, 2006
Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc (2013) 5.27
Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation (2013) 1.45
Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl) (2010) 1.27
Coffee consumption and risk of stroke in women. Circulation (2009) 1.22
Caffeine's Vascular Mechanisms of Action. Int J Vasc Med (2010) 1.05
Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes (2012) 1.01
Coffee, decaffeinated coffee, caffeine, and tea consumption in young adulthood and atherosclerosis later in life: the CARDIA study. Arterioscler Thromb Vasc Biol (2010) 1.00
Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia (2009) 0.98
Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: the Strong Heart Study. Nutr Metab Cardiovasc Dis (2010) 0.94
Habitual coffee consumption and blood pressure: an epidemiological perspective. Vasc Health Risk Manag (2008) 0.93
Caffeine consumption and incident atrial fibrillation in women. Am J Clin Nutr (2010) 0.92
Coffee consumption and risk of heart failure in men: an analysis from the Cohort of Swedish Men. Am Heart J (2009) 0.83
Long-term, moderate coffee consumption is associated with lower prevalence of diabetes mellitus among elderly non-tea drinkers from the Mediterranean Islands (MEDIS Study). Rev Diabet Stud (2007) 0.77
Espresso coffee consumption and risk of coronary heart disease in a large Italian cohort. PLoS One (2015) 0.77
Coffee Consumption and Stroke Risk: A Meta-analysis of Epidemiologic Studies. Korean J Fam Med (2012) 0.76
Relationship of Caffeine with Adiponectin and Blood Sugar Levels in Subjects with and without Diabetes. J Clin Diagn Res (2015) 0.75
Cognitive Performance and Mood Following Ingestion of a Theacrine-Containing Dietary Supplement, Caffeine, or Placebo by Young Men and Women. Nutrients (2015) 0.75
Associations of Coffee, Tea, and Caffeine Intake with Coronary Artery Calcification and Cardiovascular Events. Am J Med (2016) 0.75
Chronic Caffeine Administration Attenuates Vascular Injury-Induced Neointimal Hyperplasia in Rats. J Caffeine Res (2013) 0.75
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
Adherence to Mediterranean diet and health status: meta-analysis. BMJ (2008) 4.16
Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr (2010) 3.99
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol (2007) 3.20
Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study. J Am Coll Cardiol (2013) 2.56
Long-term prognostic role of uric acid in patients with ST-elevation myocardial infarction and renal dysfunction. J Cardiovasc Med (Hagerstown) (2015) 2.30
Seasonal blood pressure changes: an independent relationship with temperature and daylight hours. Hypertension (2013) 2.30
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology (2002) 2.26
Carotid artery stenting: first consensus document of the ICCS-SPREAD Joint Committee. Stroke (2006) 2.21
Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil (2008) 2.14
Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Liver Int (2011) 2.14
Mechanical ventilation in the early phase of ST elevation myocardial infarction treated with mechanical revascularization. Cardiol J (2013) 2.06
Weather-related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management. Hypertension (2005) 2.05
Strong-ion gap approach in patients with cardiogenic shock following ST-elevation myocardial infarction. Acute Card Care (2013) 2.03
Abnormal troponin level as short-term predictor of poor outcome in acute atrial fibrillation. Am J Emerg Med (2013) 2.02
Comparison of the degree of platelet aggregation inhibition with prasugrel versus clopidogrel and clinical outcomes in patients with unprotected left main disease treated with everolimus-eluting stents. Am J Cardiol (2013) 2.00
Cryptogenic myocardial infarction in young patients: which is the optimal diagnostic and therapeutic management? Arch Iran Med (2013) 1.99
Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation. Eur Heart J (2007) 1.93
EXCAVATOR: detecting copy number variants from whole-exome sequencing data. Genome Biol (2013) 1.90
Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet (2009) 1.87
Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation. Eur Heart J (2006) 1.82
Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis. Am J Med (2007) 1.76
Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. Thromb Haemost (2009) 1.75
Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail (2003) 1.70
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol (2006) 1.70
Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol (2008) 1.66
Left ventricular reverse remodeling after undersized mitral ring annuloplasty in patients with ischemic regurgitation. Ann Thorac Surg (2008) 1.65
Assessment of cardiac output in children: a comparison between the pressure recording analytical method and Doppler echocardiography. Pediatr Crit Care Med (2008) 1.64
Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents. J Am Coll Cardiol (2008) 1.64
Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism. Am J Med (2003) 1.60
Phenotypic variability of cardiovascular manifestations in Marfan Syndrome. Possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism. Eur Heart J (2003) 1.59
Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years. J Am Coll Cardiol (2009) 1.58
Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuropathy: a case-control study. Graefes Arch Clin Exp Ophthalmol (2008) 1.57
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis. Am J Cardiol (2009) 1.57
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial. J Am Coll Cardiol (2003) 1.54
Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study. Circulation (2006) 1.54
An unusual case of cardiac tamponade. J Cardiovasc Med (Hagerstown) (2006) 1.53
[Non-alcoholic fatty liver disease: a new challenge for cardiologists]. G Ital Cardiol (Rome) (2010) 1.52
High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am J Med (2002) 1.50
Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy. Thromb Haemost (2007) 1.50
Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function. Thromb Haemost (2008) 1.49
Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine. Stroke (2005) 1.49
Management of acute myocardial infarction in the real world: a summary report from The Ami-Florence Italian Registry. Intern Emerg Med (2008) 1.48
Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy. Am J Clin Pathol (2009) 1.48
High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study. JACC Cardiovasc Interv (2013) 1.47
Role of hemodynamic shear stress in cardiovascular disease. Atherosclerosis (2010) 1.47
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients. Pharmacogenet Genomics (2007) 1.43
Frailty and resilience from physics to medicine. Med Hypotheses (2010) 1.43
Pharmacovigilance and use of online health information. Trends Pharmacol Sci (2013) 1.43
Preoperative cardiac assessment in patients undergoing aortic surgery: analysis of factors affecting the cardiac outcomes. Ann Vasc Surg (2010) 1.43
Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology (2005) 1.42
The evolution of the concept of 'fever' in the history of medicine: from pathological picture per se to clinical epiphenomenon (and vice versa). J Infect (2004) 1.40
Management of oral anticoagulant therapy in the real practice of an anticoagulation clinic: focus on atrial fibrillation. Blood Coagul Fibrinolysis (2005) 1.39
[Dealing with error in cardiology]. G Ital Cardiol (Rome) (2010) 1.39
Pre-participation assessment in young athletes: a state affair. Intern Emerg Med (2012) 1.38
Prognostic impact of atrial fibrillation occurrence in patients with non-ST-elevation acute coronary syndromes: is dysrhythmia duration a parameter to focus on? Intern Emerg Med (2013) 1.38
Acid-base imbalance in uncomplicated ST-elevation myocardial infarction: the clinical role of tissue acidosis. Intern Emerg Med (2009) 1.37
Minimally invasive thoracoscopic hybrid treatment of lone atrial fibrillation: early results of monopolar versus bipolar radiofrequency source. Interact Cardiovasc Thorac Surg (2012) 1.34
The diabetic cardiomyopathy. Acta Diabetol (2010) 1.32
Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol (2012) 1.30
Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis. Thromb Haemost (2010) 1.28